Metformin Iontophoresis and Physical Therapy for Knee Osteoarthritis in Postmenopausal Women
This study aims to evaluate the effectiveness of Metformin Iontophoresis and Physical Therapy in improving functional status and reducing pain intensity in postmenopausal women with knee osteoarthritis.
Metformin gel Iontophoresis
+ Iontophoresis
Arthritis+2
+ Joint Diseases
+ Musculoskeletal Diseases
Treatment Study
Summary
Study start date: March 1, 2026
Actual date on which the first participant was enrolled.This study focuses on postmenopausal women who have been diagnosed with knee osteoarthritis, a condition where the knee joints become painful and stiff. The goal is to evaluate the effectiveness of a treatment that combines a medication called Metformin, applied through a process known as iontophoresis, along with physical therapy rehabilitation. The study is important as it aims to find a potential new approach to manage knee osteoarthritis in postmenopausal women, which could lead to improved quality of life. Participants in this study are randomly assigned to either the treatment group or the control group, with neither the participants nor the outcome assessors knowing who receives which treatment. The treatment group receives Metformin through iontophoresis, a method that uses a mild electrical current to deliver the medication through the skin, along with physical therapy. The control group receives a placebo, or dummy treatment, through iontophoresis and the same physical therapy. The study measures the results by looking at changes in functional status, assessed using the WOMAC index, and pain intensity, assessed using the Visual Analog Scale.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.68 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Female
Biological sex of participants that are eligible to enroll.From 50 to 70 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Active ComparatorGroup II
Active ComparatorStudy Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location